Editorial: IgA nephropathy: a nephrologist's challenge in 2023

Fausta Catapano; Oliver Flossmann; Lucia Del Vecchio

doi:10.3389/fneph.2024.1477350

Editorial: IgA nephropathy: a nephrologist's challenge in 2023

Front Nephrol. 2024 Sep 11:4:1477350. doi: 10.3389/fneph.2024.1477350. eCollection 2024.

Authors

Fausta Catapano¹, Oliver Flossmann², Lucia Del Vecchio³

Affiliations

¹ Nephrology, Dialysis and Hypertension Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
² Berkshire Kidney Unit, Royal Berkshire Hospital, Reading, United Kingdom.
³ Department of Nephrology and Dialysis, ASST Lariana, San Fermo della Battaglia, Italy.

No abstract available

Keywords: APRIL (TNFSF13); BAFF - B-cell activating factor; IgA nephropathy; SGLT 2 inhibitor; biomarker; cathepsin S (Cat S); pathogenesis; treatment.

Publication types

Editorial